岩藻糖基化
免疫系统
细胞溶解
白细胞介素21
癌症研究
生物
免疫学
离体
淋巴因子激活杀伤细胞
自然杀伤细胞
免疫疗法
白细胞介素12
T细胞
体内
体外
分子生物学
细胞毒性T细胞
岩藻糖
糖蛋白
生物技术
生物化学
作者
Xing Tong,Yuhua Ru,Jianhong Fu,Ying Wang,Jinjin Zhu,Yiyang Ding,Fulian Lv,Menglu Yang,Xiya Wei,Chenchen Liu,Xin Liu,Lei Lei,Xiaojin Wu,Lingchuan Guo,Yang Xu,Jie Li,Peng Wu,Huanle Gong,Jia Chen,Depei Wu
标识
DOI:10.3389/fimmu.2022.904693
摘要
Natural killer (NK) cells have been demonstrated as a promising cellular therapy as they exert potent anti-tumor immune responses. However, applications of NK cells to tumor immunotherapy, especially in the treatment of advanced hematopoietic and solid malignancies, are still limited due to the compromised survival and short persistence of the transferred NK cells in vivo . Here, we observed that fucosyltransferase (FUT) 7 and 8 were highly expressed on NK cells, and the expression of CLA was positively correlated with the accumulation of NK cells in clinical B cell lymphoma development. Via enzyme-mediated ex vivo cell-surface fucosylation, the cytolytic effect of NK cells against B cell lymphoma was significantly augmented. Fucosylation also promoted NK cell accumulation in B cell lymphoma-targeted tissues by enhancing their binding to E-selectin. Moreover, fucosylation of NK cells also facilitated stronger T cell anti-tumor immune responses. These findings suggest that ex vivo fucosylation contributes to enhancing the effector functions of NK cells and may serve as a novel strategy for tumor immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI